UHS Adds $700M Delayed Draw Term Loan, Bringing 2026 Liquidity Boost to $1.1B
UHS is trading near its 52-week low of $140.08 (7.0% above the low).
Summary
UHS entered into a Twelfth Amendment to its credit agreement, adding a $700 million delayed draw term loan facility. This brings total new credit capacity in 2026 to $1.1 billion, providing substantial liquidity for general corporate purposes.
Key Events · Financing and Capital Events · UHS
-
$700M Delayed Draw Term Loan
UHS entered into a Twelfth Amendment adding a $700 million delayed draw term loan facility, available through September 30, 2026, with a 364-day maturity from funding.
-
Liquidity Expansion
Combined with the $400 million delayed draw term loan from April 2026, UHS has secured $1.1 billion in new credit capacity in 2026, enhancing financial flexibility.
-
Use of Proceeds
Proceeds are for general corporate purposes, including refinancing existing indebtedness and paying related fees and expenses.
-
Lender Commitments
Five lenders provided commitments: JPMorgan ($160M), Bank of America ($135M), Truist ($135M), U.S. Bank ($135M), and Wells Fargo ($135M).
Analysis · UHS · Industrial Applications And Services
Universal Health Services has secured a $700 million delayed draw term loan facility, lifting its total new credit capacity for 2026 to $1.1 billion. Available through September 2026, the facility matures 364 days after funding and is earmarked for general corporate purposes, including refinancing existing debt. This follows a $400 million delayed draw term loan arranged in April 2026 for the Talkspace acquisition. While the additional liquidity bolsters financial flexibility, it also raises leverage, with the new facility secured on a pari passu basis alongside existing senior secured notes. The move unfolds against a backdrop of strong Q1 earnings and a $127 million share repurchase, yet also significant legal liabilities and the termination of a key facility's Medicare/Medicaid agreement.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 29.2% of the 1496 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.63%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, UHS was trading at $149.91 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $9.1B. The 52-week trading range was $140.08 to $246.33. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.